Literature DB >> 10090892

Age estimates of two common mutations causing factor XI deficiency: recent genetic drift is not necessary for elevated disease incidence among Ashkenazi Jews.

D B Goldstein1, D E Reich, N Bradman, S Usher, U Seligsohn, H Peretz.   

Abstract

The type II and type III mutations at the FXI locus, which cause coagulation factor XI deficiency, have high frequencies in Jewish populations. The type III mutation is largely restricted to Ashkenazi Jews, but the type II mutation is observed at high frequency in both Ashkenazi and Iraqi Jews, suggesting the possibility that the mutation appeared before the separation of these communities. Here we report estimates of the ages of the type II and type III mutations, based on the observed distribution of allelic variants at a flanking microsatellite marker (D4S171). The results are consistent with a recent origin for the type III mutation but suggest that the type II mutation appeared >120 generations ago. This finding demonstrates that the high frequency of the type II mutation among Jews is independent of the demographic upheavals among Ashkenazi Jews in the 16th and 17th centuries.

Entities:  

Mesh:

Year:  1999        PMID: 10090892      PMCID: PMC1377831          DOI: 10.1086/302313

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  10 in total

1.  The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin.

Authors:  H Peretz; A Mulai; S Usher; A Zivelin; A Segal; Z Weisman; M Mittelman; H Lupo; N Lanir; B Brenner; O Shpilberg; U Seligsohn
Journal:  Blood       Date:  1997-10-01       Impact factor: 22.113

2.  Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes.

Authors:  J C Stephens; D E Reich; D B Goldstein; H D Shin; M W Smith; M Carrington; C Winkler; G A Huttley; R Allikmets; L Schriml; B Gerrard; M Malasky; M D Ramos; S Morlot; M Tzetis; C Oddoux; F S di Giovine; G Nasioulas; D Chandler; M Aseev; M Hanson; L Kalaydjieva; D Glavac; P Gasparini; E Kanavakis; M Claustres; M Kambouris; H Ostrer; G Duff; V Baranov; H Sibul; A Metspalu; D Goldman; N Martin; D Duffy; J Schmidtke; X Estivill; S J O'Brien; M Dean
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

3.  Origins of Old Testament priests.

Authors:  M G Thomas; K Skorecki; H Ben-Ami; T Parfitt; N Bradman; D B Goldstein
Journal:  Nature       Date:  1998-07-09       Impact factor: 49.962

Review 4.  Launching microsatellites: a review of mutation processes and methods of phylogenetic interference.

Authors:  D B Goldstein; D D Pollock
Journal:  J Hered       Date:  1997 Sep-Oct       Impact factor: 2.645

5.  Estimating the age of alleles by use of intraallelic variability.

Authors:  M Slatkin; B Rannala
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

6.  Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population.

Authors:  N Risch; D de Leon; L Ozelius; P Kramer; L Almasy; B Singer; S Fahn; X Breakefield; S Bressman
Journal:  Nat Genet       Date:  1995-02       Impact factor: 38.330

7.  Mutation of human short tandem repeats.

Authors:  J L Weber; C Wong
Journal:  Hum Mol Genet       Date:  1993-08       Impact factor: 6.150

8.  One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews.

Authors:  O Shpilberg; H Peretz; A Zivelin; R Yatuv; A Chetrit; T Kulka; C Stern; E Weiss; U Seligsohn
Journal:  Blood       Date:  1995-01-15       Impact factor: 22.113

9.  High gene frequency of factor XI (PTA) deficiency in Ashkenazi Jews.

Authors:  U Seligsohn
Journal:  Blood       Date:  1978-06       Impact factor: 22.113

10.  Failure to detect variant (CRM+) plasma thromboplastin antecedent (factor XI) molecules in hereditary plasma thromboplastin antecedent deficiency: a study of 125 patients of several ethnic backgrounds.

Authors:  H Saito; O D Ratnoff; B N Bouma; U Seligsohn
Journal:  J Lab Clin Med       Date:  1985-12
  10 in total
  21 in total

1.  Combined use of biallelic and microsatellite Y-chromosome polymorphisms to infer affinities among African populations.

Authors:  R Scozzari; F Cruciani; P Santolamazza; P Malaspina; A Torroni; D Sellitto; B Arredi; G Destro-Bisol; G De Stefano; O Rickards; C Martinez-Labarga; D Modiano; G Biondi; P Moral; A Olckers; D C Wallace; A Novelletto
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

2.  Y chromosomes traveling south: the cohen modal haplotype and the origins of the Lemba--the "Black Jews of Southern Africa".

Authors:  M G Thomas; T Parfitt; D A Weiss; K Skorecki; J F Wilson; M le Roux; N Bradman; D B Goldstein
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

3.  Geographic distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selection.

Authors:  Neil Risch; Hua Tang; Howard Katzenstein; Josef Ekstein
Journal:  Am J Hum Genet       Date:  2003-02-24       Impact factor: 11.025

4.  A 122.5-kilobase deletion of the P gene underlies the high prevalence of oculocutaneous albinism type 2 in the Navajo population.

Authors:  Zanhua Yi; Nanibaa' Garrison; Orit Cohen-Barak; Tatiana M Karafet; Richard A King; Robert P Erickson; Michael F Hammer; Murray H Brilliant
Journal:  Am J Hum Genet       Date:  2002-12-05       Impact factor: 11.025

5.  Detecting population growth, selection and inherited fertility from haplotypic data in humans.

Authors:  Frédéric Austerlitz; Luba Kalaydjieva; Evelyne Heyer
Journal:  Genetics       Date:  2003-11       Impact factor: 4.562

6.  A population-genetic test of founder effects and implications for Ashkenazi Jewish diseases.

Authors:  Montgomery Slatkin
Journal:  Am J Hum Genet       Date:  2004-06-18       Impact factor: 11.025

7.  Age and origin of the FCMD 3'-untranslated-region retrotransposal insertion mutation causing Fukuyama-type congenital muscular dystrophy in the Japanese population.

Authors:  R Colombo; A A Bignamini; A Carobene; J Sasaki; M Tachikawa; K Kobayashi; T Toda
Journal:  Hum Genet       Date:  2000-12       Impact factor: 4.132

8.  Gaucher disease: the origins of the Ashkenazi Jewish N370S and 84GG acid beta-glucosidase mutations.

Authors:  G A Diaz; B D Gelb; N Risch; T G Nygaard; A Frisch; I J Cohen; C S Miranda; O Amaral; I Maire; L Poenaru; C Caillaud; M Weizberg; P Mistry; R J Desnick
Journal:  Am J Hum Genet       Date:  2000-04-21       Impact factor: 11.025

9.  Recent origin and spread of a common Lithuanian mutation, G197del LDLR, causing familial hypercholesterolemia: positive selection is not always necessary to account for disease incidence among Ashkenazi Jews.

Authors:  R Durst; R Colombo; S Shpitzen; L B Avi; Y Friedlander; R Wexler; F J Raal; D A Marais; J C Defesche; M Y Mandelshtam; M J Kotze; E Leitersdorf; V Meiner
Journal:  Am J Hum Genet       Date:  2001-04-17       Impact factor: 11.025

10.  Origin and spread of the 1278insTATC mutation causing Tay-Sachs disease in Ashkenazi Jews: genetic drift as a robust and parsimonious hypothesis.

Authors:  Amos Frisch; Roberto Colombo; Elena Michaelovsky; Mazal Karpati; Boleslaw Goldman; Leah Peleg
Journal:  Hum Genet       Date:  2004-01-15       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.